Cargando…

Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus

OBJECTIVES: To assess the mortality in patients with diabetes mellitus (DM) following percutaneous coronary intervention (PCI) according to their insulin requirement and PCI setting (elective, urgent, and emergency). BACKGROUND: DM is a major risk factor to develop coronary artery disease (CAD). It...

Descripción completa

Detalles Bibliográficos
Autores principales: Noman, Awsan, Balasubramaniam, Karthik, Alhous, M. Hafez A., Lee, Kelvin, Jesudason, Peter, Rashid, Muhammad, Mamas, Mamas A., Zaman, Azfar G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484298/
https://www.ncbi.nlm.nih.gov/pubmed/28029209
http://dx.doi.org/10.1002/ccd.26882
_version_ 1783245858565783552
author Noman, Awsan
Balasubramaniam, Karthik
Alhous, M. Hafez A.
Lee, Kelvin
Jesudason, Peter
Rashid, Muhammad
Mamas, Mamas A.
Zaman, Azfar G.
author_facet Noman, Awsan
Balasubramaniam, Karthik
Alhous, M. Hafez A.
Lee, Kelvin
Jesudason, Peter
Rashid, Muhammad
Mamas, Mamas A.
Zaman, Azfar G.
author_sort Noman, Awsan
collection PubMed
description OBJECTIVES: To assess the mortality in patients with diabetes mellitus (DM) following percutaneous coronary intervention (PCI) according to their insulin requirement and PCI setting (elective, urgent, and emergency). BACKGROUND: DM is a major risk factor to develop coronary artery disease (CAD). It is unclear if meticulous glycemic control and aggressive risk factor management in patients with DM has improved outcomes following PCI. METHODS: Retrospective analysis of prospectively collected data on 9,224 patients treated with PCI at a regional tertiary center between 2008 and 2011. RESULTS: About 7,652 patients were nondiabetics (non‐DM), 1,116 had non‐insulin treated diabetes mellitus (NITDM) and 456 had ITDM. Multi‐vessel coronary artery disease, renal impairment and non‐coronary vascular disease were more prevalent in DM patients. Overall 30‐day mortality rate was 2.4%. In a logistic regression model, the adjusted odds ratios (95% confidence intervals [CI]) for 30‐day mortality were 1.28 (0.81–2.03, P = 0.34) in NITDM and 2.82 (1.61–4.94, P < 0.001) in ITDM compared with non‐DM. During a median follow‐up period of 641 days, longer‐term post‐30 day mortality rate was 5.3%. In the Cox's proportional hazard model, the hazard ratios (95% CI) for longer‐term mortality were 1.15 (0.88–1.49, P = 0.31) in NITDM and 1.88 (1.38–2.55, P < 0.001) in ITDM compared with non‐DM group. Similar result was observed in all three different PCI settings. CONCLUSION: In the modern era of aggressive cardiovascular risk factor control in diabetes, this study reveals higher mortality only in insulin‐treated diabetic patients following PCI for stable coronary artery disease and acute coronary syndrome. Importantly, diabetic patients with good risk factor control and managed on diet or oral hypoglycemics have similar outcomes to the non‐diabetic population. © 2016 The Authors Catheterization and Cardiovascular Interventions Published by Wiley Periodicals, Inc.
format Online
Article
Text
id pubmed-5484298
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-54842982017-07-10 Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus Noman, Awsan Balasubramaniam, Karthik Alhous, M. Hafez A. Lee, Kelvin Jesudason, Peter Rashid, Muhammad Mamas, Mamas A. Zaman, Azfar G. Catheter Cardiovasc Interv Coronary Artery Disease OBJECTIVES: To assess the mortality in patients with diabetes mellitus (DM) following percutaneous coronary intervention (PCI) according to their insulin requirement and PCI setting (elective, urgent, and emergency). BACKGROUND: DM is a major risk factor to develop coronary artery disease (CAD). It is unclear if meticulous glycemic control and aggressive risk factor management in patients with DM has improved outcomes following PCI. METHODS: Retrospective analysis of prospectively collected data on 9,224 patients treated with PCI at a regional tertiary center between 2008 and 2011. RESULTS: About 7,652 patients were nondiabetics (non‐DM), 1,116 had non‐insulin treated diabetes mellitus (NITDM) and 456 had ITDM. Multi‐vessel coronary artery disease, renal impairment and non‐coronary vascular disease were more prevalent in DM patients. Overall 30‐day mortality rate was 2.4%. In a logistic regression model, the adjusted odds ratios (95% confidence intervals [CI]) for 30‐day mortality were 1.28 (0.81–2.03, P = 0.34) in NITDM and 2.82 (1.61–4.94, P < 0.001) in ITDM compared with non‐DM. During a median follow‐up period of 641 days, longer‐term post‐30 day mortality rate was 5.3%. In the Cox's proportional hazard model, the hazard ratios (95% CI) for longer‐term mortality were 1.15 (0.88–1.49, P = 0.31) in NITDM and 1.88 (1.38–2.55, P < 0.001) in ITDM compared with non‐DM group. Similar result was observed in all three different PCI settings. CONCLUSION: In the modern era of aggressive cardiovascular risk factor control in diabetes, this study reveals higher mortality only in insulin‐treated diabetic patients following PCI for stable coronary artery disease and acute coronary syndrome. Importantly, diabetic patients with good risk factor control and managed on diet or oral hypoglycemics have similar outcomes to the non‐diabetic population. © 2016 The Authors Catheterization and Cardiovascular Interventions Published by Wiley Periodicals, Inc. John Wiley and Sons Inc. 2016-12-28 2017-06-01 /pmc/articles/PMC5484298/ /pubmed/28029209 http://dx.doi.org/10.1002/ccd.26882 Text en © 2016 The Authors Catheterization and Cardiovascular Interventions Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Coronary Artery Disease
Noman, Awsan
Balasubramaniam, Karthik
Alhous, M. Hafez A.
Lee, Kelvin
Jesudason, Peter
Rashid, Muhammad
Mamas, Mamas A.
Zaman, Azfar G.
Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus
title Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus
title_full Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus
title_fullStr Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus
title_full_unstemmed Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus
title_short Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus
title_sort mortality after percutaneous coronary revascularization: prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus
topic Coronary Artery Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484298/
https://www.ncbi.nlm.nih.gov/pubmed/28029209
http://dx.doi.org/10.1002/ccd.26882
work_keys_str_mv AT nomanawsan mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus
AT balasubramaniamkarthik mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus
AT alhousmhafeza mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus
AT leekelvin mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus
AT jesudasonpeter mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus
AT rashidmuhammad mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus
AT mamasmamasa mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus
AT zamanazfarg mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus